title: Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT.
abstract: Previous studies have shown high accuracy for immunoscintigraphy with 99mTc-MAb-174 in patients with squamous-cell carcinoma of the head and neck region compared to CT and MRI. We conducted a prospective study to determine if immunoscintigraphy provides additional diagnostic information for radiation treatment planning.
  
  
  METHODS
  Radioimmunoscintigraphy (RIS) was performed on 40 patients (planar, whole-body, SPECT) with histologically confirmed squamous-cell carcinoma (30 primary tumors, 10 recurrences) after injection of the 99mTc (1.1 GBq) labeled monoclonal anti-squamous-cell cancer antibody 174H0.64 (murine IgG1). Results were combined with information obtained by clinical examination, sonography, panendoscopy and x-ray CT. The strategy for radiation treatment and the required treatment volumes were defined with and without immunoscintigraphical findings.
  
  
  RESULTS
  Additional diagnostically relevant information from RIS was obtained from 10 patients (25%) with advanced tumors or recurrences. In three patients (7.5%), the treatment volume had to be extended. The therapeutic strategy for seven patients (17.5%) had to be changed due to the detection of metastatic disease beyond the head and neck region. RIS of patients with squamous-cell cancers of the head and neck region with 99mTcMAb-174H0.64 enabled the detection of tumors that were not depicted by other conventional diagnostic imaging procedures.
  
  
  CONCLUSIONS
  The use of RIS in radiation treatment planning of advanced tumors of the head and neck region appears to yield important diagnostic information that may alter patient management.
authors.affiliation: Department of Radiotherapy, Johann Wolfgang Goethe University Medical Center, Frankfurt/Main, Germany.
authors.forename: I A
authors.initials: IA
authors.lastname: Adamietz
authors.forename: R P
authors.initials: RP
authors.lastname: Baum
authors.forename: F
authors.initials: F
authors.lastname: Schemman
authors.forename: A
authors.initials: A
authors.lastname: Niesen
authors.forename: R
authors.initials: R
authors.lastname: Knecht
authors.forename: F
authors.initials: F
authors.lastname: Saran
authors.forename: S
authors.initials: S
authors.lastname: Tieku
authors.forename: G R
authors.initials: GR
authors.lastname: Boniface
authors.forename: G
authors.initials: G
authors.lastname: Hör
authors.forename: H D
authors.initials: HD
authors.lastname: Böttcher
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016719:Radioimmunodetection; D013667:Technetium; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D013667:Technetium